"With 7 additional phase 3 readouts expected in 2026..." -- Kenneth Custer, PhD, EVP Lilly Cardiometabolic Health TRIUMPH-1 -- Obesity -- RESULTS (May 2026) TRIUMPH-1 is the pivotal general-obesity trial that forms the basis of Lilly's weight-management regulatory submission
[6] [15] An international consensus panel recommends against using tranexamic acid during breastfeeding in patients with hereditary angioedema caused by C1 inhibitor deficiency
PLoS One 7(10):e47713 Tilg H, Zmora N, Adolph TE, Elinav E (2020) The intestinal microbiota fuelling metabolic inflammation
Injection site reactions, if they occur, usually appear within hours of administration and resolve within a few days
Pharmaceuticals are a tightly regulated industry for the safety of our population, and any goods sold outside the regulatory frameworks are a cause for concern. The Maementcurves.com site, portraying itself as Australian, claimed the product had even saved the life of a customer who had been seriously obese and close to death
